At 3.2% CAGR, Neurovascular Devices Market Size Set to Register 3,878.51 million USD by 2027

(AmericaNewsHour via Comtex)

Market Study Report adds new research on Neurovascular Devices market, which is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysis, application potential, and the regional growth landscape, Neurovascular Devices market also includes an in-depth study of the industrys competitive scenario.

The global neurovascular devices market is expected to reach US$ 3,878.51 Mn in 2027 from US$ 2,919.41 Mn in 2018. The neurovascular devices market is estimated to grow with a CAGR of 3.2% from 2019-2027.

The market is driven by the factors such as, increasing incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, factor such as high cost of embolization coils and lack of expert professionals are the major restraining factors for the growth of the market. A minimally invasive medical procedure is generally carried out by inserting a small device or an implant in body through an incision or anatomical opening. Minimally invasive procedures are being performed widely in the recent years. Since these incisions are tiny, the patient recovers at a faster rate comparatively, with less discomfort. Some of the benefits of a minimally invasive procedure include, few small cuts, less trauma to the muscles, nerves and tissues, less bleeding & scarring, less tissue injury, less trauma to organs, less pain, faster oral intake and less hospital stay.

Request a sample of this premium report at  

Key Company Profiles

  • Medtronic plc
  • Stryker Corporation
  • Johnson & Johnson Services, Inc (DePuy Synthes)
  • Penumbra, Inc.
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Acandis GmbH & Co. KG.
  • Integer Holdings Corporation.
  • Memry Corporation
  • phenox GmbH

Global neurovascular devices market was segmented by product, application and end user. On the basis of the product the market is segmented as neuro thrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. Based on the application the market is segmented into cerebral aneurysms, ischemic strokes, arteriovenous malformation & fistulas and other applications. And the market is classified into hospitals, ambulatory surgical centers and specialized clinics on the basis of end user. Some of the major primary and secondary sources included in the report for the neurovascular devices market are Brazilian Institute of Neuroscience and Neurotechnology, Food and Drug Administration, Centers for Disease Control and Prevention, and others.

Products such as neurovascular embolization & coiling assist devices including embolic coils, flow diversion devices and liquid embolic agents are widely being used in the field of neurology. Embolic coils are used to isolate an aneurysm from the normal circulation without blocking off any small arteries nearby or narrowing the main vessel. Coil embolization is a minimally invasive procedure to treat an aneurysm by filling it with material that closes off the sac and reduces the risk of bleeding. It is performed from “within” the artery (endovascular) through a steerable catheter inserted into the blood stream at the groin and guided to the brain. Tiny coils, glue, or mesh stents are used to promote clotting and close off the aneurysm.

After the coil embolization procedure the patient is admitted for a duration of around 12 to 24 hours. Once the vital organs are back to their normal functioning, the patient is allowed to go home. Time taken for the coil embolization for the neurological procedure (unruptured aneurysm) is between an hour and a half and three hours. In addition, the rise in the awareness about the minimally invasive procedures and availability of the reimbursement for the minimally invasive procedures are likely to foster the demand for minimally invasive procedure. Thus, owing to these factors the market for the neurovascular devices is likely to propel at a significant rate during the forecast period.

Request a discount on standard prices of this premium report at


1. Introduction

2. Global Neurovascular Devices Market Key Takeaways

3. Research Methodology

4. Global Neurovascular Devices Market Landscape

5. Global Neurovascular Devices Market Key Industry Dynamics

6. Neurovascular Devices Market Global Analysis

7. Neurovascular Devices Market Analysis And Forecasts To 2027 Product

8. Neurovascular Devices Market Analysis And Forecasts To 2027 Application

10. Neurovascular Devices Market Revenue And Forecasts To 2027 Regional Analysis

11. Neurovascular Devices Market Industry Landscape

12. Neurovascular Devices Market Key Company Profiles

12.1 Medtronic plc

12.2 Stryker Corporation

12.3 Johnson & Johnson Services, Inc (DePuy Synthes)

12.4 Penumbra, Inc.

12.5 Terumo Corporation

12.6 MicroPort Scientific Corporation

12.7 Acandis GmbH & Co. KG.

12.8 Integer Holdings Corporation.

12.9 Memry Corporation

12.10 phenox GmbH

13. Appendix

buying decision on this premium report  

About Us: allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975


Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: [email protected]



The post At 3.2% CAGR, Neurovascular Devices Market Size Set to Register 3,878.51 million USD by 2027 appeared first on America News Hour.